Navigation Links
CPR Data Debriefing by Hospital Responders Improves CPR Performance and Increases Initial Survival Rate Following Cardiac Arrest
Date:5/26/2008

Study published in Archives of Internal Medicine supports use of Q-CPR(TM)

technology to improve CPR quality

ANDOVER, Mass., May 26 /PRNewswire-FirstCall/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the results of a study confirming the benefit of using CPR sensing and recording technology to improve CPR performance. Published in the Archives of Internal Medicine, the study revealed that providing objective metrics and educational feedback to medical personnel who performed CPR on a cardiac arrest patient significantly improved ventilation rate, compression rate and depth of compression. This improvement in CPR performance in a clinical setting was associated with higher initial survival rates for cardiac arrest patients.

"Similar to post-game analysis for professional athletes, medical responders were able to learn from their past resuscitation performance and apply this knowledge to future resuscitations," said Dr. Dana Edelson, director of Clinical Research for the Emergency Resuscitation Center at the University of Chicago Medical Center, and co-investigator of the study. "The results of this study suggest that CPR performance review has broad applicability for improving resuscitation training."

Results drawn from medical professionals participating in the Resuscitation with Actual Performance Integrated Debriefing (RAPID) trials were published in the study, "Improving In-Hospital Cardiac Arrest Process and Outcomes using Performance Debriefing." The Philips HeartStart MRx with Q-CPR Measurement and Feedback was used to record resuscitation performance during actual cardiac arrest events. Medical professionals then participated in weekly debriefing sessions to review trans
'/>"/>

SOURCE Royal Philips Electronics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 1DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 2DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 3Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 1Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 1Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 3